SCHEMBL1122844

SCHEMBL1122844

O=C(NC(Cc1c[nH]c2ccc(OCc3ccccc3)cc12)C(=O)O)c1cccc(OCCN(Cc2ccccc2)Cc2ccccc2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
PPARG P37231 1/20 0.59
GPR132 Q9UNW8 7/20 0.58
HSP90AA1 P07900 1/20 0.54
HSP90AB1 P08238 1/20 0.54
LTA4H P09960 1/20 0.54
PLA2G2A P14555 1/20 0.54
CCKBR P32239 1/20 0.53
MMP2 P08253 1/20 0.51
MMP13 P45452 1/20 0.51
MMP14 P50281 1/20 0.51
ADAM17 P78536 1/20 0.51
MRGPRX4 Q96LA9 1/20 0.51
CMKLR2 P46091 1/20 0.49
CMKLR1 Q99788 1/20 0.49
TACR1 P25103 1/20 0.49
LNPEP Q9UIQ6 2/20 0.48
ERAP2 Q6P179 2/20 0.47
ERAP1 Q9NZ08 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123375 0.94 PPARG (0.65) MEN1KMT2APPARGGPR132HSP90AA1
SCHEMBL1122887 0.93 TACR1 (0.54) MEN1KMT2APPARGGPR132HSP90AA1
SCHEMBL1122981 0.91 ITGB2 (0.52) MEN1KMT2APPARGGPR132ADAM17
SCHEMBL1122892 0.87 PPARG (0.56) MEN1KMT2APPARGHSP90AA1HSP90AB1
SCHEMBL1123056 0.84 PPARG (0.54) MEN1KMT2APPARGADAM17MRGPRX4
SCHEMBL1122929 0.83 PPARG (0.59) MEN1KMT2APPARGMRGPRX4TACR1
SCHEMBL1123378 0.80 GPR132 (0.57) GPR132CMKLR2CMKLR1
SCHEMBL27635939 0.80 PPARG (0.88) MEN1KMT2APPARGGPR132HSP90AA1
SCHEMBL27635940 0.80 PPARG (0.88) MEN1KMT2APPARGGPR132HSP90AA1
SCHEMBL5921666 0.80 MEN1 (0.67) MEN1KMT2APPARGGPR132HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
CN-1835914-A New benzamides as PPAR[upsilon] modulators S A L V A T LAB SA (ES) 2006-09-20 CN disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG MEN1 4877/4885KMT2A 1515/4885PPARG 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.